First, antibody D effectively prevented the induction of tau pathology in the brains of transgenic mice that had been injected with human Alzheimer’s disease brain extracts, showing that it could effectively neutralize the pathological species present in these extracts. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.